KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Dividends Paid - Common (2016 - 2025)

Historic Dividends Paid - Common for Thermo Fisher Scientific (TMO) over the last 14 years, with Q3 2025 value amounting to $163.0 million.

  • Thermo Fisher Scientific's Dividends Paid - Common rose 866.67% to $163.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $623.0 million, marking a year-over-year increase of 929.82%. This contributed to the annual value of $583.0 million for FY2024, which is 1147.23% up from last year.
  • Thermo Fisher Scientific's Dividends Paid - Common amounted to $163.0 million in Q3 2025, which was up 866.67% from $162.0 million recorded in Q2 2025.
  • Over the past 5 years, Thermo Fisher Scientific's Dividends Paid - Common peaked at $163.0 million during Q3 2025, and registered a low of $87.0 million during Q2 2021.
  • Over the past 5 years, Thermo Fisher Scientific's median Dividends Paid - Common value was $135.0 million (recorded in 2023), while the average stood at $127.9 million.
  • As far as peak fluctuations go, Thermo Fisher Scientific's Dividends Paid - Common soared by 1839.08% in 2021, and later skyrocketed by 866.67% in 2025.
  • Thermo Fisher Scientific's Dividends Paid - Common (Quarter) stood at $103.0 million in 2021, then grew by 13.59% to $117.0 million in 2022, then grew by 16.24% to $136.0 million in 2023, then grew by 9.56% to $149.0 million in 2024, then rose by 9.4% to $163.0 million in 2025.
  • Its Dividends Paid - Common was $163.0 million in Q3 2025, compared to $162.0 million in Q2 2025 and $149.0 million in Q1 2025.